Use of Arterio-venous Fistula as First Choice for Intravenous Drug Administration in Kidney Transplant Recipients (PerFAV)

University Hospital, Angers

Status: Unknown

Conditions: Evaluate the Risks of Using Arteriovenous Fistula as First Choise for Drug Administration

Study type: Observational

Funder types: Other

Identifiers

NCT02874391

PHRIP-15-633

Details and patient eligibility

About

Use of arteriovenous fistula for IV drug administration is controversial and often prohibited by nephrologists. However, we have been using this method in our department for years now in order to keep the patients 'veins for other fistulas in the future. The aim of this study is to evaluate our practice and maybe provide a justification for a larger multi-center study given the importance of this subject in patients with chronic renal failure.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age > 18 years, functional AV fistula, new kidney transplant recipient

Exclusion criteria

• Prothetic AV fistula, Very recent AV fistula of less than 3 months

Trial design

50 participants in 2 patient groups

AV fistula group

Control group